HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,881,893 | +15.0% | 85,417 | +2.3% | 0.04% | +22.2% |
| Q2 2023 | $8,589,312 | -7.4% | 83,513 | -1.8% | 0.04% | -14.3% |
| Q1 2023 | $9,277,555 | -2.8% | 85,006 | +1.1% | 0.04% | -8.7% |
| Q4 2022 | $9,540,423 | +78.7% | 84,042 | -2.6% | 0.05% | +70.4% |
| Q3 2022 | $5,338,000 | -22.5% | 86,254 | -0.1% | 0.03% | -15.6% |
| Q2 2022 | $6,888,000 | -28.9% | 86,366 | -6.2% | 0.03% | -15.8% |
| Q1 2022 | $9,691,000 | -8.5% | 92,119 | -5.6% | 0.04% | +2.7% |
| Q4 2021 | $10,597,000 | -1.5% | 97,580 | -0.7% | 0.04% | -9.8% |
| Q3 2021 | $10,759,000 | +15.7% | 98,228 | -1.1% | 0.04% | +17.1% |
| Q2 2021 | $9,300,000 | -1.8% | 99,320 | -3.5% | 0.04% | -7.9% |
| Q1 2021 | $9,471,000 | +16.0% | 102,904 | -11.9% | 0.04% | +11.8% |
| Q4 2020 | $8,168,000 | +852.0% | 116,772 | +956.7% | 0.03% | +750.0% |
| Q3 2020 | $858,000 | – | 11,051 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |